Company Filing History:
Years Active: 1976
Title: The Innovations of James Mahan
Introduction
James Mahan is an accomplished inventor based in Syracuse, NY (US). He is known for his significant contributions to the field of pharmaceuticals, particularly in the preparation of valuable intermediates for semi-synthetic cephalosporins. His work has had a lasting impact on the development of antibiotics.
Latest Patents
James Mahan holds a patent for a process related to the preparation of 7-aminocephalosporanic acids. This patent, which is crucial for the synthesis of semi-synthetic cephalosporins, outlines a method that involves cleaving the amide bond of specific compounds. The invention claims the use of dicyclohexylamine or diisopropylamine as a substitute for a tertiary amine acid scavenger in the halogenation step of the process. He has 1 patent to his name.
Career Highlights
Mahan has made significant strides in his career while working at Bristol-Myers Company. His innovative approach to pharmaceutical chemistry has positioned him as a key figure in the development of new antibiotic compounds. His expertise in the field has been recognized and valued by his peers.
Collaborations
Throughout his career, James Mahan has collaborated with notable colleagues, including David A. Johnson and Steven P. Brundidge. These collaborations have further enhanced the quality and impact of his work in the pharmaceutical industry.
Conclusion
James Mahan's contributions to the field of pharmaceuticals, particularly through his patent on the preparation of 7-aminocephalosporanic acids, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of important antibiotic therapies.